$2.130
-0.199 (-9.36%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
TARA Prediction & Forecast by Similar Chart Analysis
Alphio's TARA stock price prediction model matches the current Protara Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $2.16 (+1.51%). The 1-week path is $2.18 (+2.23%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Protara Therapeutics Inc Stock?
Protara Therapeutics Inc (TARA) is currently priced at $2.41, which is significantly below its 52-week high of $7.82, indicating potential upside. However, the stock has a low RSI of 40.11, suggesting it is nearing oversold conditions, but the recent net loss of $21.7 million in Q2 2026 raises concerns about its financial health. Given these factors, it may be prudent to hold rather than buy at this time, as the company is still facing significant financial challenges despite a strong cash position of $177.4 million expected to fund operations through 2028.
TARA stock price ended at $2.13 on Thursday, after losing -9.36%
Protara Therapeutics Inc (TARA) last closed at $2.1300001, losing -9.36%. These facts feed the 1-day and 1-week TARA price prediction above.
Forecast Drivers
Protara Therapeutics Inc (TARA) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches TARA, ranked by similarity.
Seasonality analysis for TARA
Historically the probability of a positive November return for TARA is 65.12%. December offers the highest probability of a positive month at 69.77%, while September is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for TARA
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Nov 2026 | $2.38 | $2.92 | $3.53 | +37.25% |
| Dec 2026 | $3.58 | $3.72 | $4.28 | +74.61% |
In 2026, Protara Therapeutics Inc (TARA) is projected to range from $2.38 to $4.28.
Protara Therapeutics Inc 2026 monthly forecast
In Nov 2026, Protara Therapeutics Inc is projected to average $2.92, with a low of $2.38 and high of $3.53.
In Dec 2026, Protara Therapeutics Inc is projected to average $3.72, with a low of $3.58 and high of $4.28.
Related articles
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.